PE20061200A1 - Proceso y compuesto para la preparacion de derivados de naftilindol sustituidos - Google Patents

Proceso y compuesto para la preparacion de derivados de naftilindol sustituidos

Info

Publication number
PE20061200A1
PE20061200A1 PE2006000111A PE2006000111A PE20061200A1 PE 20061200 A1 PE20061200 A1 PE 20061200A1 PE 2006000111 A PE2006000111 A PE 2006000111A PE 2006000111 A PE2006000111 A PE 2006000111A PE 20061200 A1 PE20061200 A1 PE 20061200A1
Authority
PE
Peru
Prior art keywords
compound
alkyl
aryl
cycloalkyl
procedure
Prior art date
Application number
PE2006000111A
Other languages
English (en)
Inventor
Dragan Vladimir A
John Richard Potoski
Jean Louise Helom
Xinxu Shi
Wayne G Mcmahon
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20061200A1 publication Critical patent/PE20061200A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UN PROCEDIMIENTO QUE COMPRENDE EN HACER RECCIONAR UN COMPUESTO DE FORMULA 2, CON UN COMPUESTO DE PREFERENCIA 5-CLOROMETIL-1H-TETRAZOL (CMT) PROTEGIDO CON TETRAHIDROPIRANO; DONDE R1, R2, R3 Y R4 SON CADA UNO H, ALQUILO C1-C3, CICLOALQUILO C3-C5, -CH2-(CICLOALQUILO C4-C6), ENTRE OTROS; R5 ES H, ALQUILO C1-C6, PERFLUOROALQUILO C1-C6, ARILO C6-C14, ENTRE OTROS; R6 ES H, ALQUILO C1-C6, ALQUILARILO C8-C20, BENCILO SUSTITUIDO O NO, ENTRE OTROS. DICHO PROCESO REQUIERE UNA BASE SELECCIONADA ENTRE CARBONATO ALCALINO, HIDROXIDO ALCALINO, FOSFINA, ENTRE OTROS PARA PRODUCIR UN COMPUESTO DE FORMULA 1, DONDE R7 ES H, ALQUILO C1-C6, ARILALQUILO C7-C20, ARILO C6-C14, ENTRE OTROS; n ES 0-6; X ES UN GRUPO SALIENTE. UN COMPUESTO OBTENIDO DE ESTE PROCEDIMIENTO ES 1-BENCIL-3-PENTIL-2-[6-(1H-TETRAZOL-5-ILMETOXI)NAFTALEN-2-IL]-1H-INDOL, SIENDO ESTE INHIBIDOR-1 DEL ACTIVADOR DE PLASMINOGENO (PAI-1) UTIL EN EL TRATAMIENTO DE TROMBOSIS DE VENA PROFUNDA, ENFERMEDAD CARDIACA CORONARIA, FIBROSIS PULMONAR, ENTRE OTROS
PE2006000111A 2005-01-27 2006-01-26 Proceso y compuesto para la preparacion de derivados de naftilindol sustituidos PE20061200A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64761805P 2005-01-27 2005-01-27

Publications (1)

Publication Number Publication Date
PE20061200A1 true PE20061200A1 (es) 2006-12-19

Family

ID=36570379

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000111A PE20061200A1 (es) 2005-01-27 2006-01-26 Proceso y compuesto para la preparacion de derivados de naftilindol sustituidos

Country Status (21)

Country Link
US (2) US7323483B2 (es)
EP (1) EP1856104A1 (es)
JP (1) JP2008528618A (es)
KR (1) KR20070103744A (es)
CN (1) CN101111491A (es)
AR (1) AR053437A1 (es)
AU (1) AU2006208021A1 (es)
BR (1) BRPI0606871A2 (es)
CA (1) CA2595376A1 (es)
CR (1) CR9215A (es)
GT (1) GT200600032A (es)
HN (1) HN2006003347A (es)
IL (1) IL183712A0 (es)
MX (1) MX2007008952A (es)
NI (1) NI200700188A (es)
NO (1) NO20072879L (es)
PE (1) PE20061200A1 (es)
RU (1) RU2007121255A (es)
TW (1) TW200637850A (es)
WO (1) WO2006081455A1 (es)
ZA (1) ZA200706203B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070185186A1 (en) * 2006-02-03 2007-08-09 Wyeth Compositions for the delivery of substituted napthyl indole derivatives and methods of their use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903206A1 (en) 1989-09-07 1991-03-13 Abbott Lab Indole-, benzofuran-, and benzothiophene-containing¹lipoxygenase-inhibiting compounds
US5151435A (en) 1991-04-08 1992-09-29 Merck & Co., Inc. Angiotensin ii antagonists incorporating an indole or dihydroindole
IL101785A0 (en) 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL109568A0 (en) 1993-05-19 1994-08-26 Fujisawa Pharmaceutical Co Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
CA2134192A1 (en) 1993-11-12 1995-05-13 Michael L. Denney 5, 6-bicyclic glycoprotein iib/iiia antagonists
US5552412A (en) 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
NZ318228A (en) 1995-09-01 1999-07-29 Lilly Co Eli Indolyl neuropeptide y receptor antagonists
CA2264020A1 (en) 1996-08-26 1998-03-05 Jean Bemis Inhibitors of phospholipase enzymes
US6703527B2 (en) * 2001-05-24 2004-03-09 Nikken Chemicals Co., Ltd. Method for oxidation of allyl alcohol
TWI224101B (en) * 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
TW591020B (en) 2001-06-20 2004-06-11 Wyeth Corp 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)

Also Published As

Publication number Publication date
GT200600032A (es) 2006-11-14
RU2007121255A (ru) 2009-03-10
CR9215A (es) 2007-11-23
BRPI0606871A2 (pt) 2009-07-21
NI200700188A (es) 2008-05-09
NO20072879L (no) 2007-06-26
JP2008528618A (ja) 2008-07-31
TW200637850A (en) 2006-11-01
US7323483B2 (en) 2008-01-29
ZA200706203B (en) 2009-12-30
KR20070103744A (ko) 2007-10-24
CA2595376A1 (en) 2006-08-03
HN2006003347A (es) 2011-03-30
WO2006081455A1 (en) 2006-08-03
IL183712A0 (en) 2007-09-20
AU2006208021A1 (en) 2006-08-03
MX2007008952A (es) 2007-09-18
US20080071091A1 (en) 2008-03-20
EP1856104A1 (en) 2007-11-21
US20060183917A1 (en) 2006-08-17
CN101111491A (zh) 2008-01-23
AR053437A1 (es) 2007-05-09

Similar Documents

Publication Publication Date Title
CO5611131A2 (es) Derivados de 5-feniltiazol y su uso como inhibidores de pi3 cinasa
AR054130A1 (es) Procedimiento para la preparacion de 1-alquil-3-feniluracilos
CL2018003021A1 (es) Compuestos heteroaril-1,2,4-triazol y heteroaril-tetrazol
PE20071223A1 (es) Procedimiento de preparacion de derivados de acil-amino-alquilen-amida
AR061644A1 (es) Derivados de benzofurano
AR049784A1 (es) Derivados sustituidos de morfolina y tiomorfolina
NO341531B1 (no) Sykliske anilino-pyridinotriaziner
CR10509A (es) Derivados de cinamoil-piperazina y su utilizacion como antagonistas de par-1
PE20060297A1 (es) Nuevos derivados fluoroglicosidicos de pirazoles como inhibidores de sglt 1
ECSP045468A (es) Nuevas proteínas de fusión con trombomodulina dirigidas contra factores tisulares como anticoagulantes
PE20071321A1 (es) Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores de gamma secretasa relacionados
PE20081174A1 (es) Inhibidores de metaloproteasas derivados de heterociclos
PE20080842A1 (es) Benzoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus
AR054688A1 (es) Alquil-piridinas como inhibidores 11-beta de la diabetes
PE20060604A1 (es) Derivados del tetrahidronaftaleno como agentes antiinflamatorios y procedimiento para su preparacion
PE20110196A1 (es) 5-alquinil-pirimidinas
AR066962A1 (es) Compuesto heterociclico fusionado
PH12019501391A1 (en) Novel compound and pharmacologically acceptable salt thereof
PE20090548A1 (es) Compuestos aza-biciclohexano como inhibidores de trombina
PE20220904A1 (es) Compuestos de 4,4a,5,7,8,8a-hexapirido[4,3-b][1,4]oxazin-3-ona como inhibidores de magl
AR057464A1 (es) Procedimiento para la preparacion de derivados de sulfonamida
CL2020002579A1 (es) Compuesto de fenoxiurea y un agente de control de plagas.
PE20061200A1 (es) Proceso y compuesto para la preparacion de derivados de naftilindol sustituidos
AR075763A1 (es) N-alcoxicarboxamidas sustituidas con heterociclos, composiciones microbiocidas que las contienen y metodo para el control y/o prevencion de infestaciones fungicas en plantas.
PE20090602A1 (es) Nuevos compuestos

Legal Events

Date Code Title Description
FD Application declared void or lapsed